Delivery Order SPE2DE24D0013-SPE2D625F6UJ3

The U.S. Defense Department's Medical Supply Chain awarded a $7,907.58 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, involves molecular diagnostic testing solutions, specifically reagents and assays for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The work will be performed in Sunnyvale, California, and no small business set-aside designation was utilized for this award. This delivery order likely falls under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans Affairs, which provide the company a framework for delivering molecular diagnostic systems and testing capabilities across multiple federal healthcare networks.

Cepheid, a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, specializes in GeneXpert diagnostic systems and associated reagents for infectious disease detection. The company holds significant federal contracting relationships with the Department of Veterans Affairs, Defense Logistics Agency, and Defense Health Agency, with two major IDV contracts valued at $32.8 million and $2.5 million respectively. These contracts enable Cepheid to provide continuous procurement of diagnostic testing solutions to federal healthcare systems, supporting clinical and laboratory microbiology testing for conditions including COVID-19, influenza, RSV, and other infectious diseases across the Veterans Integrated Service Networks and broader defense healthcare infrastructure.